These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 229714)

  • 1. Structure-activity relationships for kininase II inhibition by lower homologs of the bradykinin potentiating peptide BPP9a.
    Fisher GH; Ryan JW; Martin LC; Pena GA
    Adv Exp Med Biol; 1979; 120B():651-63. PubMed ID: 229714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis and biological activity of analogs of a nonapeptide inhibitor of peptidyldipeptidase].
    Filatova MP; Krit NA; Beschastnaia NV; Blokhina AV; Kozlova NI
    Bioorg Khim; 1985 Jan; 11(1):21-30. PubMed ID: 2985089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superactive inhibitors of angiotensin converting enzyme: analogs of BPP9a containing dehydroproline.
    Fisher GH; Ryan JW
    FEBS Lett; 1979 Nov; 107(2):273-6. PubMed ID: 228972
    [No Abstract]   [Full Text] [Related]  

  • 4. Solid phase synthesis of retro-inverso peptide analogues. Synthesis and biological activity of the partially modified retro-inverso analogue of the bradykinin potentiating peptide BPP9a [gLys6, (RS)-mPhe7, Ala8] BPP9a.
    Bonelli F; Pessi A; Verdini AS
    Int J Pept Protein Res; 1984 Dec; 24(6):553-6. PubMed ID: 6099336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bradykinin analogs as inhibitors of angiotensin-converting enzyme.
    Chaturvedi D; Huelar E; Gunthorpe M; Gofman M; Krapf DS; Apostol E; Lewis WS
    Pept Res; 1993; 6(6):308-12. PubMed ID: 8292848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new bradykinin-potentiating peptide (TmF) from Trimeresurus mucrosquamatus.
    Jia YH; Li DS; Zhu SW; Zhang LY; Ding LS; Wang WY; Xiong YL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):619-23. PubMed ID: 12883631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a bradykinin potentiating peptide (BPP-S) isolated from Scaptocosa raptoria venom.
    Ferreira LA; Alves WE; Lucas MS; Habermehl GG
    Toxicon; 1996 May; 34(5):599-603. PubMed ID: 8783454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II).
    Dorer FE; Stewart JM; Ryan JW
    Experientia; 1978 Nov; 34(11):1436. PubMed ID: 214326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for rabbit brain neuropeptide-metabolizing peptidases. Inhibition of endopeptidase B by bradykinin potentiating peptide 9a (SQ 20881).
    Martins AR; Caldo H; Coelho HL; Moreira AC; Antunes-Rodrigues J; Greene LJ; Martins de Camargo AC
    J Neurochem; 1980 Jan; 34(1):100-7. PubMed ID: 6161209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-dependent hypertension--potential pitfalls in definition.
    Williams GH
    N Engl J Med; 1977 Mar; 296(12):684-5. PubMed ID: 190538
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
    Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA
    Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of a bradykinin potentiating nonapeptide (BPP9a) on prolonged haemorrhagic shock in dogs.
    Errington ML; Rocha e Silva Júnior M
    J Physiol; 1973 Aug; 233(1):46P-47P. PubMed ID: 4357201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthesis and effect of affinity-labeled analogs and partial sequences of the bradykinin potentiating nonapeptide BPP9 alpha (teprotide)].
    Reissmann S; Paegelow I; Filatova MP; Krit NA; Arold H
    Pharmazie; 1985 May; 40(5):314-7. PubMed ID: 3898147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of bradykinin-potentiating peptide 9a after intravenous injection.
    Martin LC; Ryan JW; Fisher GH; Chung A; Epstein M; Stewart JM
    Biochem J; 1979 Dec; 184(3):713-6. PubMed ID: 540061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of two potentiating peptides (KPP and BPP9a) on kinin-induced rat paw edema.
    Fernandes PD; Guimarães JA; Assreuy J
    Agents Actions; 1991 Mar; 32(3-4):182-7. PubMed ID: 1862741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function studies on the bradykinin potentiating peptide from Chinese snake venom (Agkistrodon halys Pallas).
    Chi CW; Wang SZ; Xu LG; Wang MY; Lo SS; Huang WD
    Peptides; 1985; 6 Suppl 3():339-42. PubMed ID: 3008123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular dichroism spectra of some lower homologs of bradykinin potentiating peptide 9 alpha.
    Marlborough DI; Fisher GH; Ryan JW
    Arch Biochem Biophys; 1981 Aug; 210(1):43-8. PubMed ID: 6271072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synthesis and analysis of conformationally restricted analogs of peptide inhibitors of the angiotensin-converting enzyme].
    Filatova MP; Krit NA; Komarova OM; Orekhovich VN; Reissmann S
    Bioorg Khim; 1986 Jan; 12(1):59-70. PubMed ID: 3004512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin degrading activity in cultured human endothelial cells.
    Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.